Search Results - "Lycke, N Y"

Refine Results
  1. 1

    Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses by Bergqvist, P, Stensson, A, Hazanov, L, Holmberg, A, Mattsson, J, Mehr, R, Bemark, M, Lycke, N Y

    Published in Mucosal immunology (2013)
    “…Whereas gut IgA responses to the microbiota may be multi-centered and diverse, little is known about IgA responses to T-cell-dependent antigens following oral…”
    Get full text
    Journal Article
  2. 2

    The regulation of gut mucosal IgA B-cell responses: recent developments by Lycke, N Y, Bemark, M

    Published in Mucosal immunology (01-11-2017)
    “…The majority of activated B cells differentiate into IgA plasma cells, with the gut being the largest producer of immunoglobulin in the body. Secretory IgA…”
    Get full text
    Journal Article
  3. 3

    Cholera toxin adjuvant promotes a balanced Th1/Th2/Th17 response independently of IL-12 and IL-17 by acting on Gsα in CD11b+ DCs by Mattsson, J, Schön, K, Ekman, L, Fahlén-Yrlid, L, Yrlid, U, Lycke, N Y

    Published in Mucosal immunology (01-07-2015)
    “…Despite an extensive literature on the mechanism of action of cholera toxin (CT), we still lack critical information about how the toxin acts as an adjuvant…”
    Get full text
    Journal Article
  4. 4

    Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization by VAJDY, M, LYCKE, N. Y

    Published in Immunology (01-03-1992)
    “…This study was conducted to investigate whether cholera toxin (CT), used as a mucosal adjuvant, would promote the development in mice of immunological memory…”
    Get full text
    Journal Article
  5. 5

    IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection by Bromander, AK, Ekman, L, Kopf, M, Nedrud, JG, Lycke, NY

    Published in The Journal of immunology (1950) (01-06-1996)
    “…Using IL-6-deficient (IL-6 -/-) or wild-type mice, we investigated whether IL-6 is involved in the intestinal adjuvant activity of cholera toxin (CT) and to…”
    Get full text
    Journal Article
  6. 6

    Interferon‐γ receptor‐deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance by KJERRULF, M., GRDIC, D., EKMAN, L., SCHÖN, K., VAJDY, M., LYCKE, N. Y.

    Published in Immunology (01-09-1997)
    “…Interferon‐γ (IFN‐γ) receptor knock‐out (IFN‐γR−/−) mice were used to analyse the role of IFN‐γ in mucosal immune responses following oral immunization. We…”
    Get full text
    Journal Article
  7. 7

    Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin- specific protective immunity despite normal gut mucosal IgA differentiation by Hornquist, CE, Ekman, L, Grdic, KD, Schon, K, Lycke, NY

    Published in The Journal of immunology (1950) (15-09-1995)
    “…Using normal and CD4 gene-targeted (CD4-/-) mice, we asked whether mucosal immune responses and IgA B cell differentiation require the presence of CD4+ T…”
    Get full text
    Journal Article
  8. 8

    Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation by Lycke, NY

    Published in The Journal of immunology (1950) (01-06-1993)
    “…In a recent study we provided evidence that isotype switching in LPS-stimulated murine B cells was greatly enhanced by cholera toxin (CT). We found that CT…”
    Get full text
    Journal Article
  9. 9

    Impaired CD40‐Signalling in CD19‐Deficient Mice Selectively Affects Th2‐Dependent Isotype Switching by Gärdby, E., Chen, X.‐J., Lycke, N. Y.

    Published in Scandinavian journal of immunology (01-01-2001)
    “…Activation of B lymphocytes involves binding of antigen to the specific receptor and signalling through several membrane coreceptors, of which CD19 has been…”
    Get full text
    Journal Article
  10. 10

    Antigen-specific and polyclonal CD4+ lamina propria T-cell lines phenotypic and functional characterization by HARRIMAN, G. R, HORNQVIST, E, LYCKE, N. Y

    Published in Immunology (1992)
    “…Surface phenotype and function of lamina propria CD4+ T cells have been evaluated. In addition, long-term, antigen-specific and polyclonal lamina propria CD4+…”
    Get full text
    Journal Article
  11. 11

    Gene expression profiling identifies STAT3 as a novel pathway for immunomodulation by cholera toxin adjuvant by Sjöblom-Hallén, A, Marklund, U, Nerstedt, A, Schön, K, Ekman, L, Bergqvist, P, Löwenadler, B, Lycke, N Y

    Published in Mucosal immunology (01-07-2010)
    “…Earlier studies have reported on both proinflammatory and anti-inflammatory activities of cholera toxin (CT). As CT is a powerful adjuvant, we were interested…”
    Get full text
    Journal Article
  12. 12

    Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit by Agren, LC, Ekman, L, Lowenadler, B, Lycke, NY

    Published in The Journal of immunology (1950) (15-04-1997)
    “…Cholera toxin (CT) is an exceptionally potent adjuvant but, unfortunately, also very toxic. Here we present a powerful new approach to separate toxicity from…”
    Get full text
    Journal Article
  13. 13

    Adjuvanticity of the Cholera Toxin A1-Based Gene Fusion Protein, CTA1-DD, Is Critically Dependent on the ADP-Ribosyltransferase and Ig-Binding Activity by Agren, Lena C, Ekman, Lena, Lowenadler, Bjorn, Nedrud, John G, Lycke, Nils Y

    Published in The Journal of immunology (1950) (15-02-1999)
    “…The ADP-ribosylating enterotoxins, cholera toxin (CT) and Escherichia coli heat-labile toxin, are among the most powerful immunogens and adjuvants yet…”
    Get full text
    Journal Article
  14. 14

    Requirements for B7-CD28 costimulation in mucosal IgA responses: paradoxes observed in CTLA4-H gamma 1 transgenic mice by Gärdby, E, Lane, P, Lycke, N Y

    Published in The Journal of immunology (1950) (01-07-1998)
    “…The block in the CD80/CD86-CD28/CTLA-4 pathway in CTLA4-H gamma 1 transgenic (Tg) mice results in strongly impaired systemic IgG immunity and failure to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    CD19‐deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA‐isotype switching in Peyer's patches by Gärdby, Eva, Lycke, Nils Y.

    Published in European journal of immunology (01-07-2000)
    “…CD19 exhibits a critical role as a response regulator in B cells, influencing activation, differentiation and survival. Accordingly, CD19‐deficient mice…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Lack of Local Suppression in Orally Tolerant CD8-Deficient Mice Reveals a Critical Regulatory Role of CD8+ T Cells in the Normal Gut Mucosa by Grdic, Dubravka, Hornquist, Elisabeth, Kjerrulf, Martin, Lycke, Nils Y

    Published in The Journal of immunology (1950) (15-01-1998)
    “…We found that feeding keyhole limpet hemocyanin (KLH) to CD8-deficient (CD8-/-) mice induced oral tolerance that was comparable in both magnitude and quality…”
    Get full text
    Journal Article
  19. 19

    Mucosal Vaccine Development Based on Liposome Technology by Höök, Fredrik, Bally, Marta, Norling, Karin, Bernasconi, Valentina, Lycke, Nils Y.

    Published in Journal of immunology research (01-01-2016)
    “…Immune protection against infectious diseases is most effective if located at the portal of entry of the pathogen. Hence, there is an increasing demand for…”
    Get full text
    Journal Article
  20. 20